Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
EssilorLuxottica SA

Start price
Target price
Perf. (%)
€118.75
05.06.17
€130.00
18.05.18
1.16%
18.05.18

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Future proof or reliable business model
buy
Novo Nordisk A/S

Start price
Target price
Perf. (%)
€37.89
03.05.17
€46.00
27.07.17
-6.89%
27.07.17

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€113.94
19.04.17
€125.00
26.06.17
7.94%
26.06.17

buy
Novo Nordisk A/S

Start price
Target price
Perf. (%)
€33.95
11.04.17
€53.00
28.06.18
20.00%
28.06.18

buy
Genmab A/S

Start price
Target price
Perf. (%)
€191.57
14.03.17
€210.00
14.09.17
1.07%
14.09.17

buy
Teva Pharmaceutical Industries Ltd ADR

Start price
Target price
Perf. (%)
€30.26
13.02.17
€36.09
13.04.17
-3.46%
13.04.17

buy
Bayer AG

Start price
Target price
Perf. (%)
€107.03
26.01.17
€125.00
07.06.17
12.55%
07.06.17

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
buy
Bayer AG

Start price
Target price
Perf. (%)
€101.60
04.01.17
€110.00
08.03.17
4.87%
08.03.17

Could be worthwhile Investment >10% per year
buy
Thermo Fisher Scientific Inc.

Start price
Target price
Perf. (%)
€136.85
21.11.16
€150.00
21.02.17
10.28%
21.02.17

buy
BioMarin Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€84.92
10.11.16
€108.24
10.05.17
-4.12%
10.05.17

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€71.74
10.11.16
€85.00
18.04.17
8.26%
18.04.17

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€70.39
22.10.16
€75.00
09.12.16
-2.64%
09.12.16

buy
Bayer AG

Start price
Target price
Perf. (%)
€89.85
07.10.16
€98.00
19.12.16
9.10%
19.12.16

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€70.48
30.09.16
€98.00
08.09.26
12.95%
09:52

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
buy
Humana Inc.

Start price
Target price
Perf. (%)
€158.54
23.09.16
€180.40
14.11.16
14.31%
14.11.16

buy
Becton, Dickinson & Co.

Start price
Target price
Perf. (%)
€156.38
09.09.16
€171.38
30.01.17
1.59%
30.01.17

buy
Novo Nordisk A/S

Start price
Target price
Perf. (%)
€40.86
08.09.16
€46.00
02.02.17
-22.26%
02.02.17

buy
Smith & Nephew plc

Start price
Target price
Perf. (%)
€13.52
31.08.16
€14.85
28.02.17
-1.78%
28.02.17

buy
Novo Nordisk A/S ADR

Start price
Target price
Perf. (%)
€42.39
30.08.16
€50.00
02.02.17
-25.03%
02.02.17

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€72.50
05.08.16
€85.69
03.01.18
-3.74%
03.01.18

buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€130.19
20.07.16
€150.00
10.11.16
2.02%
10.11.16

buy
Lonza Group AG

Start price
Target price
Perf. (%)
€148.64
23.06.16
€172.00
06.09.16
16.04%
06.09.16

buy
Amgen Inc.

Start price
Target price
Perf. (%)
€140.86
09.06.16
€180.40
02.04.18
11.59%
02.04.18

buy
Celgene Corp.

Start price
Target price
Perf. (%)
€90.87
09.05.16
€120.00
09.11.16
19.67%
09.11.16

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€80.73
29.04.16
€100.00
28.03.17
-20.63%
28.03.17

Could be worthwhile Investment >10% per year
Capable Management
Top 10 in its market
Known brand